B7-H4蛋白在上皮性卵巢癌中的研究进展
被引量:1
摘要
在妇科恶性肿瘤中卵巢癌(ovariancancer,OC)的发病率居第3位,仅次于子宫颈癌及子宫体癌,而其致死率却居于首位。由于卵巢解剖部位位于盆腔深部,卵巢癌早期症状多隐匿,
出处
《实用临床医学(江西)》
CAS
2012年第4期134-136,共3页
Practical Clinical Medicine
参考文献23
-
1Ratto C,Costa R,Vassallo C,et al.Twelve-year experience with left atrial resection in the treatment of non--small cell lung cancer [J].Ann Thorac Surg,2004,78(1 ):234-237.
-
2Boyle P,Levin B.Wodd cancer report 2008 [M].Lyon Cedex : IARC Press, 2008:422-423.
-
3Fields M,Chevlen E.Ovarian cancer screening:a look at the evidenee[J].Clin J Oneol Nurs,2006,10( 1 ):77-81.
-
4Tringler B,Liu W,Corral L,et al.B7-H4 overexpression in ovarian tumors[J].Gynecol Oncol, 2006,100( 1 ):44-52.
-
5左宏玲,杨艳华,徐春琳.协同共刺激分子B7-H4与肿瘤关系的研究进展[J].河北医科大学学报,2010,31(1):116-118. 被引量:1
-
6Sica G L,Choi I H,Zhu G,et al.B7-H4,a molecule of the B7 family,negatively regulates T cell immunity [J]. Immunity, 2003,18 (6) :849-861.
-
7Prasad D V,Rieards S,Mal X M,et al.B7S1 ,a novel B7 family member that negatively regulates T cell activation [ J ] .Immunity, 2003,18 (6) :863-873.
-
8Zang X ,Loke P, Kim J ,et al.B7x:a widely expressed B7 family member that inhibits T cell activation [J].Proc Natl Acad Sci USA,2003,100(18):10388-10392.
-
9Zang X,Thompson R H,A1 Ahmadie H A,et al.B7-H3and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome[J]. Proc Natl Acad Sci USA,2007,104(49):19458-19463.
-
10TringIer B,Zhuo S,Pilkington G,et al.B7-H4 is highly expressed in ductal and lobular breast cancer [J].Clin Cancer Res, 2005,11 (5): 1842-1848.
二级参考文献40
-
1Yi-xiang MAO,Yong-Jing CHEN,Yan GE,Hong-bing MA,Jian-feng YU,Hong-ya WU,Yu-min HU,Qin WANG,Qin SHI,Xue-guang ZHANG.Recombinant human B7-H4 expressed in Escherichia coli inhibits T lym-phocyte proliferation and IL-2 secretion in vitro[J].Acta Pharmacologica Sinica,2006,27(6):741-746. 被引量:16
-
2孙玉萍,刘杰,崔霞,赵东,刘惠萍,汪运山.B7-H4在结直肠癌组织中表达的临床意义[J].山东大学学报(医学版),2006,44(6):590-592. 被引量:14
-
3葛蕙心,畅继武.B7-1、GPI及其拼接在肿瘤免疫治疗中的应用进展[J].山东医药,2006,46(29):78-79. 被引量:2
-
4Fromowitz FB, Voilg MV, Chaos M, et al. Ras p21 expression in the progression of brain cancer [ J ]. Human Pathol, 1987, 18 ( 4 ) : 1268-1275.
-
5Siea GL, Choi IH, Zhu G, et al. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity [J]. Immunity, 2003, 18 (6) :849-861.
-
6Prasad DV, Richards S, Mai XM, et al. B7S1, a novel B7 family member that negatively regulates T cell activation [ J ]. Immunity, 2003,18 ( 6 ) :863-873.
-
7Tringler B, Liu WH . B7-H4 overexpression in ovarian tumors [J]. Gynecologic Oncology, 2006, 105 (1): 44-52.
-
8乐杰.妇产科学[M].6版.人民卫生出版社,2005:330-344.
-
9Simon I, Katsaros L. B7-H4 is over-expressed in early-stage ovarian cancer and is independent of CA125 expression [ J]. Gynecologic Oncology,2007, 106 (2) :334-341.
-
10曹泽毅.中华妇产科学[M].2版.人民卫生出版社,2004:1736-1780.
共引文献11
-
1华建江,姜健,胡国艳,郑淑华,刘伟,吕晶,徐军发.胃癌患者血清可溶性B7-H4的检测及其临床意义[J].山东大学学报(医学版),2009,47(8):100-102. 被引量:1
-
2廖林虹,于晓红.B7-H4在卵巢浆液性癌组织中的表达及其临床意义[J].实用癌症杂志,2010,25(5):473-475. 被引量:2
-
3何素丽,杜丹丽.B7-H4、hK6用于卵巢癌早期诊断的研究进展[J].蚌埠医学院学报,2009,34(11):1051-1052. 被引量:3
-
4左宏玲,杨艳华,徐春琳.协同共刺激分子B7-H4与肿瘤关系的研究进展[J].河北医科大学学报,2010,31(1):116-118. 被引量:1
-
5何素丽,杜丹丽.B7-H4蛋白及CA125在卵巢上皮性癌患者血清中的表达及其临床意义[J].中华妇产科杂志,2010,45(6):455-457. 被引量:8
-
6廖林虹,吴芳庚,于晓红.B7-H4在原发性卵巢上皮性癌中的表达及临床病理意义[J].南昌大学学报(医学版),2010,50(8):12-15.
-
7华建江,姜健,吴雄君,窦宇红,刘镇平,徐军发.新肿瘤标志物sB7-H4初探[J].国际检验医学杂志,2011,32(5):576-578. 被引量:2
-
8张波,买买提.吐尔逊木明,庞作良.血清可溶性B7-H4在非小细胞肺癌患者中的表达及临床意义[J].山东医药,2012,52(20):84-86. 被引量:4
-
9廖林虹,于晓红.卵巢上皮-间质肿瘤中B7-H3、B7-H4的表达及临床病理意义[J].临床与实验病理学杂志,2012,28(7):775-779. 被引量:2
-
10谢敏瑚,王亚萍,卢志贤.血清可溶性B7-H4在淋巴瘤患者诊断中的临床意义[J].放射免疫学杂志,2012,25(4):442-443. 被引量:4
同被引文献29
-
1王敏,郭丽.卵巢癌患者体内可溶型Fas水平测定及其免疫诊断学意义[J].中华医学研究与实践,2004,2(5):4-5. 被引量:1
-
2Hoechst B, Ormandy LA, Ballmaier M, et al. A new population of myeloid-derived suppressor cells in hepatocel: lular carcinoma patients induces CIM CD25 Foxp3 T cells [ J ]. Gastroenterology, 2008,135 ( 1 ) :234-243.
-
3Lesokhin AM, Hohl TM, Kitano S, et al. MonoeyticCCR2 myeloid- derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment [ J]. Cancer Res,2012,72(4) :876-886.
-
4Yokoyama I, Waxman F. Differential susceptibility of immunecomp- lexs to release from the erythrocyte CR, receptor by factort [J ]. Mol Immunol, 1994,31 (4) :227.
-
5Chang B, Liu G, Yang G, et al. REDD1 is required tbr RAS. media ted transformation of human ovarian epithelial cells [ J ]. Cell Cycle ,2009,8 (5) :780-786.
-
6Kottakis F, Polytarchou C, Foltopoulou P, et al. FGF-2 regulates cell proliferation, migration, and angiogenesis through an NDY1/ KDM2B-mir-101 -EZH2 pathway [ J ]. Molecular Cell, 2011,43 : 285 -298.
-
7Sharon EJ, Jonathan B, Chen XQ, et al. Polymorphisms in the FGF2 gene and risk of serous ovarian cancer: results from the Ovarian Cancer Association consortium [ J ] Twin Res Hum Genet ,2009,12 ( 3 ) :269-275.
-
8Pouzo MG, Lesurf R, Petkiewicz S, et al. Met induces mammary tunor8 with diverse histologies and. is associated with poor outcome andhuman basal breast cancer [ J ]. Pmc Natl Acad Sci USA,2009,106(31 ) :12903-12908.
-
9胡燕,朱燕文,张文辉,等.卵巢上皮性肿瘤患者术前检测血清SE-CAD的临床意义及其与CA125的相关性研究附77例报告[J].天津医药,2012,40(6):583-584.
-
10Hertweck MK, Erdfelderf, Kreuzer, KA et al. CD44 in hematolog- ical neoplasias [ J ]. Ann Hematol,2011,90 (5) :493-508.
二级引证文献6
-
1杨双祥,黄娅芬,王军玲,吴小涛.中西医结合治疗对晚期卵巢癌的生存率和免疫学等指标的影响分析[J].中国临床研究,2015,28(8):1090-1091. 被引量:9
-
2韩凤娟,沈影.试论中医体质与卵巢癌发病的微观因子中介机制[J].上海中医药杂志,2015,49(12):8-10. 被引量:7
-
3周安平.贝伐单抗联合紫杉醇方案治疗卵巢癌疗效及不良反应分析[J].医学理论与实践,2016,29(16):2155-2156. 被引量:4
-
4沈影,韩凤娟.中医体质可调论应用于卵巢癌防治的探索性研究——基于34例卵巢癌患者体质类型与糖类抗原CA199、CA125的相关性分析[J].天津中医药大学学报,2020,39(3):286-293. 被引量:8
-
5胡婷婷,孙婷,李凌波.红细胞RhE抗原对卵巢癌患者围术期免疫功能及预后的影响[J].临床血液学杂志(输血与检验),2020,33(6):817-820. 被引量:2
-
6贾书韬,周宏宇.三阴性乳腺癌免疫微环境特征及免疫治疗进展[J].世界肿瘤研究,2025,15(1):24-38.
-
1郭莉婷,陈颖,程月新,邵伟伟,顾晓怡,姜藻.胃癌组织中B7-H4的表达及其临床意义[J].东南大学学报(医学版),2010,29(3):306-311. 被引量:2
-
2廖林虹,于晓红.B7-H4在卵巢浆液性癌组织中的表达及其临床意义[J].实用癌症杂志,2010,25(5):473-475. 被引量:2
-
3李春仙,李美红,王峰.非小细胞肺癌患者血清可溶性B7-H4检测的临床意义[J].中国卫生检验杂志,2015,25(10):1582-1583. 被引量:7
-
4杜辉,徐春琳,左宏玲,杨艳华,王英,路晓琳.B7-H4蛋白在上皮性卵巢癌中的表达及临床意义[J].河北医科大学学报,2010,31(3):291-293.
-
5张羽,陈曾燕.B7-H4在上皮性卵巢癌中的表达及意义[J].临床肿瘤学杂志,2013,18(12):1104-1107. 被引量:3
-
6陈春燕,眭文妍,李维,罗招阳.B7-H4和FOXP3在乳腺癌中的表达及临床意义[J].现代生物医学进展,2009,9(22):4279-4282. 被引量:1
-
7赵枰,曹兴建,张秀琳,郁超,鲁晓燕,王咏梅.上皮性卵巢癌患者血清B7-H4蛋白水平的测定及其临床意义[J].中华全科医师杂志,2011,10(4):260-262. 被引量:1
-
8王高燕,朱振龙,李子良,王旭,傅天,孔令红.食管鳞癌组织中B7-H4、CD_3表达变化及意义[J].山东医药,2014,54(38):57-59. 被引量:1
-
9何素丽,谢文莲,杜丹丽.B7-H4与CA125联合检测应用于卵巢癌早期诊断的研究[J].山西医药杂志(下半月),2013,42(5):495-498.
-
10郭莉婷,程月新,姜藻.胃癌中B7-H4和B7-H3的表达及薏苡仁酯对表达的影响[J].现代肿瘤医学,2011,19(9):1791-1795. 被引量:7